Landos Biopharma

+$0.1074 (+17.53%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LABP and other ETFs, options, and stocks.

About LABP

Landos Biopharma, Inc. engages in the development and commercialization of novel therapeutics for autoimmune diseases. The firm offers BT-11, a novel, oral, gut-restricted therapeutic candidate for the treatment of ulcerative colitis and Crohn’s disease that targets the LANCL2 pathway.

CEO
Tim M. Mayleben
Employees
46
Headquarters
Blacksburg, Virginia
Founded
2017

LABP Key Statistics

Market cap
29.11M
Price-Earnings ratio
—
Dividend yield
—
Average volume
116.02K
High today
$0.75
Low today
$0.58
Open price
$0.6129
Volume
91.60K
52 Week high
$16.17
52 Week low
$0.5501

LABP Earnings

-$0.52
-$0.31
-$0.09
$0.12
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 28, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure